BIOA vs ZBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 20, 2026

BIOA

45.4
AI Score
VS
ZBIO Wins

ZBIO

59.0
AI Score

Investment Advisor Scores

BIOA

45score
Recommendation
HOLD

ZBIO

59score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric BIOA ZBIO Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 1.6% -100.0% BIOA
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 45.4/100 59.0/100 ZBIO
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY ZBIO

Relative Price Performance (Last 90 Days)

BIOA 1M: -29.9% · 3M: -74.6% ZBIO 1M: -4.7% · 3M: -7.1%

Current Technical Phase

BIOA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -35.7%), weak momentum, RSI 31

RSI (14): 31.4 · Price: $5.53

ZBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 51.4 · Price: $28.23

Fundamentals Snapshot

Metric BIOA ZBIO
Market Cap — —
Forward P/E -2.2 -6.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -1.0%
Gross Margin -7.5% -212.5%
Operating Margin -12.0% -77.7%
EPS -2.39 -9.63
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ZBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.